244 related articles for article (PubMed ID: 18924451)
1. New approaches to the treatment of opioid-induced constipation.
Holzer P
Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1(0 1):119-27. PubMed ID: 18924451
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of constipation in chronic pain patients].
Shimoyama N; Shimoyama M
Masui; 2013 Jul; 62(7):822-8. PubMed ID: 23905405
[TBL] [Abstract][Full Text] [Related]
3. Opioids and opioid receptors in the enteric nervous system: from a problem in opioid analgesia to a possible new prokinetic therapy in humans.
Holzer P
Neurosci Lett; 2004 May; 361(1-3):192-5. PubMed ID: 15135926
[TBL] [Abstract][Full Text] [Related]
4. Opioid receptors in the gastrointestinal tract.
Holzer P
Regul Pept; 2009 Jun; 155(1-3):11-7. PubMed ID: 19345246
[TBL] [Abstract][Full Text] [Related]
5. Treatment of opioid-induced gut dysfunction.
Holzer P
Expert Opin Investig Drugs; 2007 Feb; 16(2):181-94. PubMed ID: 17243938
[TBL] [Abstract][Full Text] [Related]
6. Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal?
Holzer P
Curr Pharm Des; 2012; 18(37):6010-20. PubMed ID: 22747544
[TBL] [Abstract][Full Text] [Related]
7. Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects.
Yuan CS
J Support Oncol; 2004; 2(2):111-7; discussion 119-22. PubMed ID: 15328815
[TBL] [Abstract][Full Text] [Related]
8. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies.
Kurz A; Sessler DI
Drugs; 2003; 63(7):649-71. PubMed ID: 12656645
[TBL] [Abstract][Full Text] [Related]
9. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
Foss JF
Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
[TBL] [Abstract][Full Text] [Related]
10. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
Holder RM; Rhee D
Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
[TBL] [Abstract][Full Text] [Related]
11. Peripherally Acting μ-Opioid Receptor Antagonists in the Management of Postoperative Ileus: a Clinical Review.
Chamie K; Golla V; Lenis AT; Lec PM; Rahman S; Viscusi ER
J Gastrointest Surg; 2021 Jan; 25(1):293-302. PubMed ID: 32779081
[TBL] [Abstract][Full Text] [Related]
12. Off-label uses of alvimopan and methylnaltrexone.
Rodriguez RW
Am J Health Syst Pharm; 2014 Sep; 71(17):1450-5. PubMed ID: 25147168
[TBL] [Abstract][Full Text] [Related]
13. Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain.
Webster L; Jansen JP; Peppin J; Lasko B; Irving G; Morlion B; Snidow J; Pierce A; Mortensen E; Kleoudis C; Carter E
Pain; 2008 Jul; 137(2):428-440. PubMed ID: 18164818
[TBL] [Abstract][Full Text] [Related]
14. The Efficacy of Peripheral Opioid Antagonists in Opioid-Induced Constipation and Postoperative Ileus: A Systematic Review of the Literature.
Schwenk ES; Grant AE; Torjman MC; McNulty SE; Baratta JL; Viscusi ER
Reg Anesth Pain Med; 2017; 42(6):767-777. PubMed ID: 29016552
[TBL] [Abstract][Full Text] [Related]
15. Methylnaltrexone mechanisms of action and effects on opioid bowel dysfunction and other opioid adverse effects.
Yuan CS
Ann Pharmacother; 2007 Jun; 41(6):984-93. PubMed ID: 17504835
[TBL] [Abstract][Full Text] [Related]
16. Methylnaltrexone in treatment of opioid-induced constipation in a pediatric patient.
Lee JM; Mooney J
Clin J Pain; 2012 May; 28(4):338-41. PubMed ID: 21876436
[TBL] [Abstract][Full Text] [Related]
17. Opioid-induced constipation: challenges and therapeutic opportunities.
Camilleri M
Am J Gastroenterol; 2011 May; 106(5):835-42; quiz 843. PubMed ID: 21343919
[TBL] [Abstract][Full Text] [Related]
18. Peripherally acting opioid antagonists in the treatment of opiate-related constipation: a systematic review.
Becker G; Galandi D; Blum HE
J Pain Symptom Manage; 2007 Nov; 34(5):547-65. PubMed ID: 17900855
[TBL] [Abstract][Full Text] [Related]
19. Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction.
Baker DE
Rev Gastroenterol Disord; 2009; 9(3):E84-93. PubMed ID: 19898269
[TBL] [Abstract][Full Text] [Related]
20. Alvimopan.
Neary P; Delaney CP
Expert Opin Investig Drugs; 2005 Apr; 14(4):479-88. PubMed ID: 15882122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]